African drugmakers develop local treatments for sickle cell disease
Senegal’s locally manufactured hydroxyurea, alongside Nigeria’s sickle-cell research, is strengthening Africa’s response to a disease that disproportionately affects the continent—but access, affordability and wider care remain major challenges.